dsm-firmenich, a manufacturer specializing in the health, nutrition, and beauty industries, is partnering with SCN BestCo to develop and market omega-3 gummies in the U.S., leveraging dsm-firmenich’s ingredient and flavor expertise and SCN BestCo’s gummy development and manufacturing capabilities.
 
The partnership will utilize life’sOMEGA O33-P100, an algal-based omega-3 powder, to create high-load omega-3 gummies.
 
Omega-3 gummies are historically challenging to formulate due to the sensitive nature of EPA and DHA, notes dsm-firmenich, especially when it comes to achieving high-dosage levels while preserving sensory qualities. Many conventional omega-3 gummies contain less than 100 mg of EPA and DHA per two-piece serving.
 
To help address this, dsm-firmenich developed life’sOMEGA O33-P100, which incorporates the algal oil into POWDER LOC technology, which protects EPA and DHA in a shell system enabling dosages of 400 mg of EPA and DHA per two-piece serving. life’sOMEGA algal oils are produced using precision-fermented algae grown in an enclosed, inland environment to ensure purity.
 
“Omega-3s are one of the world’s most well-recognized supplements, prized for their broad benefits in human health. But despite high omega-3 awareness, innovating new formats within this realm has remained challenging – until now. We’re thrilled to embark on this new project with SCN BestCo, with the aim of setting a new standard for gummy-based omega-3 innovation to further unlock the health benefits of these nutrients in novel and appealing ways,” said Judy Underwood-Brooks, senior director of North America sales at dsm-firmenich.
 
“It’s truly an honor to join forces with dsm-firmenich, a global leader in omega-3 advancements. Our rich history of collaboration speaks volumes – being one of the first companies to utilize their MEG-3 omega-3 powder in gummy formats back in 2007, we’ve witnessed firsthand the company’s commitment to innovation in the space. Together, we’re excited to continue breaking new boundaries and deliver the next-generation of omega-3 solutions,” said Matthew Kemme, chief commercial officer at SCN BestCo.